IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1340 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Search
 
  Next article
  Previous article 
  Table of Contents
  
Resource Links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (93 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)

 
In This Article

 Article Access Statistics
    Viewed2512    
    Printed123    
    Emailed0    
    PDF Downloaded92    
    Comments [Add]    

Recommend this journal

 
CORRESPONDENCE
Year : 2004  |  Volume : 36  |  Issue : 1  |  Page : 45
 

Reply


IJP, JIPMER, Pondicherry, TN, India

Correspondence Address:
IJP, JIPMER, Pondicherry, TN, India
batmanabane@vsnl.com



How to cite this article:
Gitanjali B. Reply. Indian J Pharmacol 2004;36:45


How to cite this URL:
Gitanjali B. Reply. Indian J Pharmacol [serial online] 2004 [cited 2019 Sep 17];36:45. Available from: http://www.ijp-online.com/text.asp?2004/36/1/45/6797


The views expressed by Chauhan are very valid. These views hold good for pre and para clinical subjects too. Though I do not want to sound pessimistic, I am not sure whether a single letter would have sufficient impact to initiate changes in the list of equipment proscribed by the MCI. Many more such letters would probably be needed before we see a visible change. 

Top
Print this article  Email this article

    

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow